Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamar Zahavi

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Biomedical Reports|May 19, 2017
Accelerated carcinogenesis following liver resection in chronically inflamed livers: A window of opportunity for treatmentAmir Sonnenblick, Tamar Zahavi
Genes|September 3, 2020
The Acidic Stress Response of the Intracellular Pathogen <i>Brucella melitensis</i>: New Insights from a Comparative, Genome-Wide Transcriptome AnalysisDavid Kornspan, Tamar Zahavi, Mali Salmon-Divon
Frontiers in Microbiology|March 7, 2019
Transcriptomic Analysis of the <i>Brucella melitensis</i> Rev.1 Vaccine Strain in an Acidic Environment: Insights Into Virulence AttenuationMali Salmon-Divon, Tamar Zahavi, David Kornspan
Plos One|January 17, 2025
Unlocking prognostic potential: A genomic signature of caloric restriction in patients with epithelial ovarian cancerOri Tal, Tamar Zahavi, Liat Anabel Sinberger, et al.
Scientific Reports|November 28, 2023
Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancerLiat Anabel Sinberger, Tamar Zahavi, Amir Sonnenblick, et al.
Genomics|December 24, 2014
VennBLAST—whole transcriptome comparison and visualization toolTamar Zahavi, Gil Stelzer, Lior Strauss, et al.
Frontiers in Immunology|March 21, 2024
Exploring potential biomarkers and therapeutic targets in inflammatory bowel disease: insights from a mega-analysis approachEdia Stemmer, Tamar Zahavi, Maoz Kellerman, et al.
Genes|October 27, 2022
Alpelisib Efficacy in Hormone Receptor-Positive HER2-Negative PIK3CA-Mutant Advanced Breast Cancer Post-Everolimus TreatmentAri Raphael, Mali Salmon-Divon, Jessica Epstein, et al.
Cancer Management and Research|April 6, 2018
<i>SYK</i> expression level distinguishes control from <i>BRCA1</i>-mutated lymphocytesTamar Zahavi, Amir Sonnenblick, Yael Shimshon, et al.
Oncotarget|December 24, 2015
Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer modelTamar Zahavi, Tali Lanton, Mali Salmon Divon, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Biomedical Reports|May 19, 2017
Accelerated carcinogenesis following liver resection in chronically inflamed livers: A window of opportunity for treatmentAmir Sonnenblick, Tamar Zahavi
Genes|September 3, 2020
The Acidic Stress Response of the Intracellular Pathogen <i>Brucella melitensis</i>: New Insights from a Comparative, Genome-Wide Transcriptome AnalysisDavid Kornspan, Tamar Zahavi, Mali Salmon-Divon
Frontiers in Microbiology|March 7, 2019
Transcriptomic Analysis of the <i>Brucella melitensis</i> Rev.1 Vaccine Strain in an Acidic Environment: Insights Into Virulence AttenuationMali Salmon-Divon, Tamar Zahavi, David Kornspan
Plos One|January 17, 2025
Unlocking prognostic potential: A genomic signature of caloric restriction in patients with epithelial ovarian cancerOri Tal, Tamar Zahavi, Liat Anabel Sinberger, et al.
Scientific Reports|November 28, 2023
Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancerLiat Anabel Sinberger, Tamar Zahavi, Amir Sonnenblick, et al.
Genomics|December 24, 2014
VennBLAST—whole transcriptome comparison and visualization toolTamar Zahavi, Gil Stelzer, Lior Strauss, et al.
Frontiers in Immunology|March 21, 2024
Exploring potential biomarkers and therapeutic targets in inflammatory bowel disease: insights from a mega-analysis approachEdia Stemmer, Tamar Zahavi, Maoz Kellerman, et al.
Genes|October 27, 2022
Alpelisib Efficacy in Hormone Receptor-Positive HER2-Negative PIK3CA-Mutant Advanced Breast Cancer Post-Everolimus TreatmentAri Raphael, Mali Salmon-Divon, Jessica Epstein, et al.
Cancer Management and Research|April 6, 2018
<i>SYK</i> expression level distinguishes control from <i>BRCA1</i>-mutated lymphocytesTamar Zahavi, Amir Sonnenblick, Yael Shimshon, et al.
Oncotarget|December 24, 2015
Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer modelTamar Zahavi, Tali Lanton, Mali Salmon Divon, et al.
Pageof 2